CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Investor Relations Archive

10/08/2020

CHEPLAPHARM announces pricing of Senior Secured Notes

CHEPLAPHARM Arzneimittel GmbH Announces Pricing of €575 Million 4.375% Senior Secured Notes due 2028 $500 Million 5.500% Senior Secured Notes due 2028


more chevron_right
Investors Domain

10/07/2020

Information

Cheplapharm announces that it is in advanced negotiations to acquire additional marketing authorizations and intellectual properties for additional territory not yet owned by us for one of our…


more chevron_right
Investors Domain

10/04/2020

CHEPLAPHARM Arzneimittel GmbH Announces Offering

CHEPLAPHARM Arzneimittel GmbH Announces Offering of €1,000,000,000 (equivalent) Senior Secured Notes due 2028


more chevron_right
Investors Domain

09/09/2020

Once again CHEPLAPHARM proves its M&A competence

Cheplapharm announces the acquisition of two product portfolios from LeoPharma and Takeda


more chevron_right
Investors Domain Archive

06/22/2020

CHEPLAPHARM acquires two product portfolios

Greifswald, 06/22/2020


more chevron_right
Archive Investors Domain

06/22/2020

CHEPLAPHARM acquires two product portfolios

Greifswald, 06/22/2020


more chevron_right
Archive

05/15/2020

CHEPLAPHARM wins again

Greifswald, 05/15/2020 – The family-owned pharmaceutical company CHEPLAPHARM Arzneimittel GmbH got honoured with the highly coveted 'Axia Best Managed Companies Award' for the second time in a row.…


more chevron_right
Investor Relations

04/06/2020

CHEPLAPHARM - Quarterly Update Call Q4 / FY 2019

Cheplapharm Arzneimittel GmbH - Quarterly Update Call Q4 / FY 2019 | Wednesday, 08 April 2020, 10:30 BST | 11:30 CEST


more chevron_right
Archive

03/30/2020

Corona Virus (COVID-19) Impact on CHEPLAPHARM activities

Due to the COVID-19 situation, CHEPLAPHARM Arzneimittel GmbH is closely monitoring the potential impact on the various Supply Chains and is committed to keep a transparent approach to all involved …


more chevron_right
Archive

02/13/2020

CHEPLAPHARM moves into new building and issues inaugural bond

Almost a year after the topping-out ceremony in March 2019, the extension at the companies headquarters in Greifswald (Ziegelhof) is ready for occupancy; the employees are now gradually moving to the…


more chevron_right
Back to top expand_less